GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography

Omar Hasan Ali; Stefan Diem; Josef Aschwanden; Eva Markert; Abel-Jan Tasman; Joachim Mueller; Lukas Flatz

doi:10.1016/j.jdcr.2016.08.011

GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography

JAAD Case Rep. 2016 Oct 13;2(5):415-417. doi: 10.1016/j.jdcr.2016.08.011. eCollection 2016 Sep.

Authors

Omar Hasan Ali¹, Stefan Diem², Josef Aschwanden³, Eva Markert⁴, Abel-Jan Tasman⁵, Joachim Mueller⁶, Lukas Flatz⁷

Affiliations

¹ Department of Dermatology and Allergology, Cantonal Hospital of St Gallen, St Gallen, Switzerland; Institute of Immunobiology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
² Department of Oncology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
³ Department of Dermatology and Allergology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
⁴ Department of Pathology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
⁵ Department of Otolaryngology, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
⁶ Department of Nuclear Medicine, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
⁷ Department of Dermatology and Allergology, Cantonal Hospital of St Gallen, St Gallen, Switzerland; Institute of Immunobiology, Cantonal Hospital of St Gallen, St Gallen, Switzerland; Department of Dermatology, Zurich University Hospital, Zurich, Switzerland.

No abstract available

Keywords: 18F-FDG, fluorodesoxyglucose; BCC, basal cell carcinoma; CT, computed tomography; GLUT1, glucose transporter 1; PET, positron emission tomography; basal cell carcinoma; glucose transporter; positron emission tomography–computed tomography imaging; radiology; tumor screening.

Publication types

Case Reports